Clinical Trial Update: Assessment of Quality of Life After Adjunct Radioiodine Therapy in Patients With Differentiated Thyroid Cancer

View source ↗

Summary

This clinical trial update reports on research assessing quality of life after adjunct radioiodine therapy in patients with differentiated thyroid cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Cancer

Drugs mentioned

• Iodine-131 (Iodine-131)

Snippet

Sponsor: Southern Medical University, China | Conditions: Thyroid Neoplasms | Status: UNKNOWN